We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 21, 2021

Association Between Gout and SGLT2 Inhibitor Therapy in Patients With Type 2 Diabetes

JAMA Network Open


Additional Info

JAMA Network Open
Association of Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and Incidence of Gout in Taiwan
JAMA Netw Open 2021 Nov 01;4(11)e2135353, MC Chung, PH Hung, PJ Hsiao, LY Wu, CH Chang, MJ Wu, JJ Shieh, CJ Chung

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading